Dialogue Health Technologies Inc
TSX:CARE
Relative Value
There is not enough data to reliably calculate the relative value of CARE.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
CARE Competitors Multiples
Dialogue Health Technologies Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Dialogue Health Technologies Inc
TSX:CARE
|
345.4m CAD | 3.7 | -18.3 | -26.2 | -20 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
97.5B USD | 0.2 | 55.1 | 14 | 14 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
67.3B EUR | 0.3 | 13.1 | 7.7 | 9.8 | |
| US |
|
Cigna Corp
NYSE:CI
|
70.2B USD | 0.3 | 11.8 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
26.5B EUR | 1.2 | 20.9 | 9.8 | 14.6 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.1B EUR | 1.2 | 23.6 | 9.1 | 16.8 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.2B USD | 2 | 22.4 | 12.4 | 16.8 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.7B USD | 1.6 | 24.9 | 12 | 17.5 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11B EUR | 0.6 | 11.4 | 5.4 | 10 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.3B USD | 11.5 | -27.1 | -29.2 | -26.5 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD | 0.8 | 13.8 | 7.2 | 9.8 |